ArticleMolecular therapy oncolytics2022

HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer.

Xuli Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.